```html

Supraventricular Tachycardia (SVT) – A Comprehensive Medical Guide

Overview

Supraventricular tachycardia (SVT) is a group of abnormal heart rhythms that originate above the heart’s ventricles (the lower chambers). These arrhythmias cause the heart to beat very fast—often 150–250 beats per minute (bpm)—while the electrical signals travel through the atria or the atrioventricular (AV) node.

Who it affects

• Adults of any age, but the most common types (AVNRT and AVRT) are seen in people aged 20–40.
• Children and adolescents can also develop SVT, especially certain congenital accessory‑pathway forms.
• Women are slightly more likely than men to be diagnosed (≈55 % vs. 45 %).

Prevalence

• SVT accounts for roughly 1–2 % of the general population.
• In the United States, an estimated 300,000–500,000 new diagnoses are made each year.
• About 1 in 600 people will experience an SVT episode at some point in their life.

Symptoms

Symptoms vary by the type of SVT, how fast the heart is beating, and individual tolerance. Most people feel a sudden “flutter” or “racing” sensation.

Common symptoms

• Palpitations – a rapid, pounding, or fluttering heartbeat.
• Dizziness or Light‑headedness – due to reduced cardiac output.
• Shortness of breath – especially during an episode or with exertion.
• Chest discomfort – pressure, tightness, or mild pain (rarely severe).
• Fatigue – lingering tiredness after an episode ends.
• Swelling of the neck veins (JVD) – in severe cases when the heart can’t pump effectively.

Less common but important symptoms

• Blurred or “tunnel‑vision” vision.
• Cold sweats.
• Anxiety or feeling of impending doom.
• Syncope (fainting) – indicates a dangerous drop in blood flow.
• Palpable “pulses” in the neck (carotid pulse) that feel rapid.

Episodes often start and stop abruptly, lasting from a few seconds to several hours. In many people, symptoms are triggered by caffeine, alcohol, stress, or physical exertion.

Causes and Risk Factors

Underlying mechanisms

SVT arises when an abnormal electrical pathway or a re‑entrant circuit causes rapid impulses to fire above the ventricles. The two most common mechanisms are:

• Atrioventricular Nodal Re‑entry Tachycardia (AVNRT) – a loop within or near the AV node.
• Atrioventricular Re‑entry Tachycardia (AVRT) – involves an accessory pathway (e.g., Wolff‑Parkinson‑White syndrome).

Less common forms include atrial tachycardia, atrial flutter, and focal atrial fibrillation that manifest as SVT.

Risk factors

• Genetic predisposition (familial WPW or other conduction system anomalies).
• Structural heart disease (congenital heart defects, repaired tetralogy of Fallot).
• Thyroid hyperfunction (hyperthyroidism).
• Electrolyte disturbances (low potassium or magnesium).
• Stimulant use – caffeine, nicotine, cocaine, certain decongestants.
• Alcohol bingeing (“holiday heart syndrome”).
• Pregnancy – hormonal changes and increased blood volume can precipitate SVT.
• Stress, anxiety, or lack of sleep.

Diagnosis

Clinical evaluation

The first step is a thorough history and physical exam. Clinicians ask about the onset, duration, triggers, and symptoms, and listen for a rapid regular rhythm on the stethoscope.

Electrocardiographic tests

• Resting 12‑lead ECG – may capture the arrhythmia if the episode is ongoing.
• Event monitor or Holter monitor – wearable devices that record heart rhythm over 24–48 hours (Holter) or several weeks (event monitor).
• Implantable loop recorder – for infrequent episodes; implanted beneath the skin.
• Electrophysiology (EP) study – an invasive test where catheters map the heart’s electrical pathways. It is diagnostic and therapeutic (allows immediate catheter ablation).

Additional tests when indicated

• Blood tests: thyroid panel, electrolytes, cardiac enzymes if chest pain is present.
• Echocardiogram – assesses heart structure and function, ruling out structural disease.
• Stress test – distinguishes SVT from exercise‑induced sinus tachycardia.

Diagnosis is confirmed when the ECG shows a regular, narrow‑complex tachycardia (QRS < 0.12 s) with a rate > 150 bpm, and the clinical picture matches SVT.

Treatment Options

Acute management (stopping an episode)

1. Vagal maneuvers – simple actions that stimulate the vagus nerve and may break the re‑entrant circuit.
   • Valsalva maneuver (blow into a syringe for 15 seconds).
   • Cold water face immersion (“diving reflex”).
   • Carotid sinus massage (performed only by trained professionals).
2. Medications
   • Intravenous adenosine – rapid bolus; stops most SVT within seconds (first‑line in the emergency department).
   • Beta‑blockers (e.g., metoprolol, propranolol) – reduce AV nodal conduction.
   • Calcium‑channel blockers (e.g., diltiazem, verapamil) – especially useful if adenosine fails.
   • Digoxin – less commonly used due to slower onset.
3. Electrical cardioversion – synchronized shock if the patient is unstable (hypotensive, chest pain, or prolonged syncope).

Long‑term management

• Medications for prophylaxis
  • Beta‑blockers or non‑dihydropyridine calcium‑channel blockers taken daily.
  • Anti‑arrhythmic drugs (e.g., flecainide, propafenone, sotalol) for refractory cases.
• Catheter ablation – a minimally invasive, curative procedure performed by electrophysiologists. Radiofrequency or cryoenergy destroys the abnormal pathway. Success rates > 90 % for AVNRT and 70–85 % for AVRT; complication rate < 2 % (Mayo Clinic).
• Implantable devices – rarely needed for SVT, but a pacemaker may be considered if ablation is contraindicated and medications cause AV block.

Lifestyle modifications

• Limit caffeine (no more than 200 mg/day) and avoid energy drinks.
• Reduce or eliminate alcohol, especially binge drinking.
• Quit smoking and avoid illicit stimulants.
• Manage stress with relaxation techniques (deep breathing, yoga, meditation).
• Maintain adequate hydration and a balanced electrolyte intake.
• Regular, moderate‑intensity exercise—after clearance from a cardiologist.

Living with Supraventricular Tachycardia (SVT)

Daily management tips

• Know your triggers – keep a symptom diary noting foods, drinks, stressors, and activity.
• Carry a “card” – a wallet‑size card that lists your diagnosis, medications, and emergency contact.
• Self‑termination techniques – practice Valsalva or cold‑water immersion for quick relief.
• Stay up to date with follow‑up appointments, especially after any medication change or ablation.
• Inform healthcare providers (dentist, surgeon, obstetrician) about your SVT history.
• Women who are pregnant should discuss SVT management early; most medications are safe, but ablation may be postponed until postpartum.

Psychosocial aspects

Episodes can be frightening and may lead to anxiety. Cognitive‑behavioral therapy (CBT) and support groups have been shown to reduce anxiety related to arrhythmias (Cleveland Clinic).

Prevention

While not all SVT can be prevented, risk can be lowered by:

• Maintaining a healthy weight (BMI < 25) to decrease cardiac strain.
• Controlling thyroid disease and other endocrine disorders.
• Correcting electrolyte imbalances—ensure adequate potassium (≥ 4 mmol/L) and magnesium (≥ 2 mg/dL).
• Limiting stimulant exposure (caffeine, nicotine, certain medications such as pseudoephedrine).
• Managing chronic stress through mindfulness, regular sleep (7–9 hours), and physical activity.

Complications

If SVT remains untreated or uncontrolled, several complications can arise:

• Heart failure – persistent high rates may weaken the myocardium over time.
• Inappropriate anticoagulation – if SVT is mistaken for atrial fibrillation, patients may receive unnecessary blood thinners.
• Syncope‑related injuries – falls from fainting can cause fractures or head trauma.
• Psychological impact – chronic anxiety, depression, and reduced quality of life.
• Rarely, sudden cardiac death – usually only when SVT coexists with other serious structural heart disease.

When to Seek Emergency Care

References

1. Mayo Clinic. “Supraventricular tachycardia (SVT).” https://www.mayoclinic.org. Accessed May 2026.
2. American Heart Association. “Adult SVT.” https://www.heart.org. Updated 2024.
3. National Institutes of Health. “Arrhythmia Diagnosis and Treatment.” https://www.nhlbi.nih.gov. 2023.
4. World Health Organization. “Cardiovascular disease fact sheet.” https://www.who.int. 2022.
5. Cleveland Clinic. “Supraventricular Tachycardia (SVT) – Symptoms, Causes, Diagnosis, Treatment.” https://my.clevelandclinic.org. 2024.
6. Johns Hopkins Medicine. “Catheter Ablation for SVT.” https://www.hopkinsmedicine.org. 2023.

```